Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis

J Dermatol. 2015 Aug;42(8):828-9. doi: 10.1111/1346-8138.12918. Epub 2015 Apr 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adalimumab*
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Infliximab*
  • Psoriasis
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Infliximab
  • Ustekinumab
  • Adalimumab